Bailey Alistair, Dalchau Neil, Carter Rachel, Emmott Stephen, Phillips Andrew, Werner Jörn M, Elliott Tim
Institute for Life Sciences, Building 85, University of Southampton, SO17 1BJ, UK.
Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, UK.
Sci Rep. 2015 Oct 20;5:14928. doi: 10.1038/srep14928.
The selection of peptides for presentation at the surface of most nucleated cells by major histocompatibility complex class I molecules (MHC I) is crucial to the immune response in vertebrates. However, the mechanisms of the rapid selection of high affinity peptides by MHC I from amongst thousands of mostly low affinity peptides are not well understood. We developed computational systems models encoding distinct mechanistic hypotheses for two molecules, HLA-B44:02 (B4402) and HLA-B44:05 (B4405), which differ by a single residue yet lie at opposite ends of the spectrum in their intrinsic ability to select high affinity peptides. We used in vivo biochemical data to infer that a conformational intermediate of MHC I is significant for peptide selection. We used molecular dynamics simulations to show that peptide selector function correlates with protein plasticity, and confirmed this experimentally by altering the plasticity of MHC I with a single point mutation, which altered in vivo selector function in a predictable way. Finally, we investigated the mechanisms by which the co-factor tapasin influences MHC I plasticity. We propose that tapasin modulates MHC I plasticity by dynamically coupling the peptide binding region and α3 domain of MHC I allosterically, resulting in enhanced peptide selector function.
主要组织相容性复合体I类分子(MHC I)在大多数有核细胞表面呈递肽段的选择对于脊椎动物的免疫反应至关重要。然而,MHC I如何从数千个大多为低亲和力的肽段中快速选择高亲和力肽段的机制尚不清楚。我们开发了计算系统模型,对两种分子HLA - B44:02(B4402)和HLA - B44:05(B4405)编码不同的机制假设,这两种分子仅相差一个残基,但在选择高亲和力肽段的内在能力方面却处于光谱的两端。我们利用体内生化数据推断MHC I的一种构象中间体对肽段选择具有重要意义。我们通过分子动力学模拟表明肽段选择功能与蛋白质可塑性相关,并通过单点突变改变MHC I的可塑性进行实验验证,结果该突变以可预测的方式改变了体内选择功能。最后,我们研究了辅助因子塔帕辛影响MHC I可塑性的机制。我们提出塔帕辛通过变构动态偶联MHC I的肽段结合区域和α3结构域来调节MHC I的可塑性,从而增强肽段选择功能。